Hyang Nina Kim, M.D.

NPI 1205876463ActiveIndividual· Internal Medicine, Infectious Disease· Seattle, WA

Internal Medicine, Infectious Disease (M.D.) in Seattle, Washington, trained at University of California, San Francisco School of Medicine (class of 1999). Their prescriptions cost Medicare Part D more than their services did: $900,610 for 1,204 claims, against $9,894 paid for services in 2024. Gilead Sciences, Inc. was the largest of 2 companies reporting payments in 2024, $8,485 in all, mostly consulting fees.

Overview

NPI	1205876463
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Jun 7, 2006
Last updated in NPPES	Mar 12, 2013

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Infectious Disease Primary	207RI0200X	MD00040285	WA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Infectious Disease (WA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	58
Services billed	136 across 12 procedure codes
Paid by Medicare	$9,894

Part D prescriptions in 2024

Prescriptions (claims)	1,204 · 1,364 30-day fills
Patients	58
Total drug cost	$900,610
Generic share	62% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of California, San Francisco School of Medicine
Graduation year	1999
Medicare specialty	Infectious Disease
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth